BioCatalyst

Drug: 5 mg BGM0504 Administered SC, Drug: : 10 mg BGM0504 Administered SC, Drug: Placebo Administered SC — catalyst calendar

2 verified catalyst event(s) referencing Drug: 5 mg BGM0504 Administered SC, Drug: : 10 mg BGM0504 Administered SC, Drug: Placebo Administered SC, each linked to its official source. Verified as of 2026-10-16.

Upcoming

DateEventCompanyDrugOfficial source & verification
2026-11-14
in 29d
ESTIMATED
 READOUT
A Study of BGM0504 in Poorly Controlled Type 2 Diabetes Patients Only Through Di
Phase 3 · Type 2 Diabetes Mellitus (T2DM)
 BrightGene Bio-Medical Technology Drug: 5 mg BGM0504 Administered SC, Drug ClinicalTrials.gov ↗
✓ Source-checked 2026-10-16
Sponsor-projected date — can change
2026-11-14
in 29d
ESTIMATED
 READOUT
A Study of BGM0504 in Participants With Type 2 Diabetes
Phase 3 · Type 2 Diabetes Mellitus (T2DM)
 BrightGene Bio-Medical Technology Drug: 5 mg BGM0504 Administered SC, Drug ClinicalTrials.gov ↗
✓ Source-checked 2026-10-16
Sponsor-projected date — can change
Disclaimer. Bio Catalyst Calendar is a public-events data calendar. Every date is sourced and linked to an official record (ClinicalTrials.gov, FDA / Federal Register, openFDA). It is scheduling and reference data only — NOT investment advice, a recommendation, or a buy/sell signal. Dates set by sponsors and the FDA can change; always confirm against the linked official source.